The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With health officials reporting 800 measles cases in multiple states already this year, most of the public – and most parents – report hearing at least one false claim about measles or the vaccine for it, and many of them aren’t sure what to believe, the latest KFF Tracking Poll on Health Information and Trust…
Funding from CDC has been a major source of support for public health programs across the U.S., but CDC is now being targeted for budget cuts by the Trump administration. To better understand how much CDC funding is provided to state and local jurisdictions, we analyzed FY 2023 funding data from CDC and present findings about much funding was provided to state and local jurisdictions, what types of public health activities were supported with this funding, and how the funding was distributed across states and regions of the U.S.
As the COVID-19 public health emergency comes to an end, about half of adults say they would be likely to get an annual COVID-19 booster. Around one in three adults don't think they have ever had COVID-19, nor have they ever tested positive for it, and they primarily attribute this to taking precautions such as avoiding crowds.
Using a combination of surveys and focus groups, the KFF COVID-19 Vaccine Monitor will track the dynamic nature of public reactions as vaccine development unfolds, including vaccine confidence and hesitancy, trusted messengers and messages, as well as the public’s experiences with vaccination as distribution begins.
This policy brief highlights areas in which HHS, FDA, and CDC have authority to shape U.S. vaccine policy with a specific focus on vaccine approvals and recommendations for the public. Ultimately, while there are limits, federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the U.S. However, this does not include imposing mandates on or changing local vaccination requirements, as those authorities rest with state and local governments.
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
This brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the National Vaccine Advisory Committee (NVAC) at the Department of Health and Human Services (HHS); and the Advisory Commission on Childhood Vaccines (ACCV) at HHS.
This finding examines how vaccine attitudes and uptake differ between Republicans who support of the Make America Great Again (MAGA) movement and those who don't, looking at uptake of the COVID-19 vaccine, the flu vaccine, and confidence in the safety of vaccines.
New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards for private health plans and how these may change in response to the COVID-19 pandemic.
This analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.
© 2026 KFF